Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal modelsHan-Yi Huang, Chi‐Huey Wong, Han‐Chieh Kao et al.|Science Translational Medicine|2022Cited by 127
Differential Receptor Binding Affinities of Influenza Hemagglutinins on Glycan ArraysHsin-Yu Liao, Chi‐Huey Wong, Che‐Hsiung Hsu et al.|Journal of the American Chemical Society|2010Cited by 93
Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibioticsTing-Jen Rachel Cheng, Wei‐Chieh Cheng, Ming-Ta Sung et al.|Proceedings of the National Academy of Sciences|2008Cited by 75
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza virusesSui‐Yuan Chang, Pan‐Chyr Yang, Kuo‐Yen Huang et al.|Scientific Reports|2021Cited by 42
Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypesHsin-Yu Liao, Chi‐Huey Wong, Shih-Chi Wang et al.|Proceedings of the National Academy of Sciences|2020Cited by 38